Genetic control of the innate immune response to Borrelia hermsii influences the course of relapsing fever in inbred strains of mice.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 2812184)

Published in Infect Immun on December 07, 2009

Authors

Vivian M Benoit1, Annett Petrich, Kishore R Alugupalli, Robin Marty-Roix, Annette Moter, John M Leong, Victor L Boyartchuk

Author Affiliations

1: Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, MA 01655, USA.

Articles cited by this

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell (1992) 17.50

Antigenic variation of Borrelia hermsii. J Exp Med (1982) 6.34

Variable major proteins of Borrellia hermsii. J Exp Med (1982) 5.62

Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity (2001) 4.92

Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity (2002) 4.87

Phylogenetic analysis of the spirochetes. J Bacteriol (1991) 4.37

The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med (1995) 3.86

B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity (2004) 2.60

Antigenic variation of a relapsing fever Borrelia species. Annu Rev Microbiol (1990) 2.37

Vector interactions and molecular adaptations of lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg Infect Dis (2002) 1.86

Linear DNA of Borrelia species and antigenic variation. Trends Microbiol (1993) 1.79

Lyme disease--United States, 2003-2005. MMWR Morb Mortal Wkly Rep (2007) 1.72

Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J Exp Med (2006) 1.69

The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol (2003) 1.67

Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d. J Immunol (2005) 1.63

Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis (1998) 1.59

Fluorescence in situ hybridization shows spatial distribution of as yet uncultured treponemes in biopsies from digital dermatitis lesions. Microbiology (1998) 1.55

Subtelomeric expression regions of Borrelia hermsii linear plasmids are highly polymorphic. Mol Microbiol (1992) 1.55

Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J Immunol (1999) 1.50

Population structure of the relapsing fever spirochete Borrelia hermsii as indicated by polymorphism of two multigene families that encode immunogenic outer surface lipoproteins. Infect Immun (1998) 1.40

Cutting edge: the spirochetemia of murine relapsing fever is cleared by complement-independent bactericidal antibodies. J Immunol (2001) 1.34

Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol Lett (2003) 1.29

The epidemiology of tick-borne relapsing fever in the United States. Am J Trop Med Hyg (2002) 1.27

The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. J Clin Invest (1999) 1.22

Mice, microbes and models of infection. Nat Rev Genet (2003) 1.20

Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses. Genes Immun (2001) 1.17

The spirochete Borrelia crocidurae causes erythrocyte rosetting during relapsing fever. Infect Immun (1998) 1.08

T-cell-independent elimination of Borrelia turicatae. Infect Immun (1984) 1.08

In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies. Infect Immun (2001) 1.05

Borrelia recurrentis characterization and comparison with relapsing-fever, Lyme-associated, and other Borrelia spp. Int J Syst Bacteriol (1997) 1.01

Spirochete-platelet attachment and thrombocytopenia in murine relapsing fever borreliosis. Blood (2003) 1.01

Characterization of protective antibodies produced in mice infected with Borrelia duttonii. Jpn J Med Sci Biol (1973) 0.99

Serial determinations of platelet counts in mice by flow cytometry. Thromb Haemost (2001) 0.93

Rapid and accurate diagnosis of human intestinal spirochetosis by fluorescence in situ hybridization. J Clin Microbiol (2009) 0.91

Cardiac apoptosis in severe relapsing fever borreliosis. Infect Immun (2005) 0.91

Irf3 polymorphism alters induction of interferon beta in response to Listeria monocytogenes infection. PLoS Genet (2007) 0.90

Platelet activation by a relapsing fever spirochaete results in enhanced bacterium-platelet interaction via integrin alphaIIbbeta3 activation. Mol Microbiol (2001) 0.87

The mammalian host response to borrelia infection. Wien Klin Wochenschr (2006) 0.87

Relapsing fever spirochetes contain chromosomal genes with unique direct tandemly repeated sequences. Infect Immun (2005) 0.86

Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease. Cleve Clin J Med (2008) 0.85

Protective activity of Borrelia duttonii-specific immunoglobulin subclasses in mice. J Med Microbiol (1997) 0.85

Articles by these authors

TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell (2012) 4.44

EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly. Dev Cell (2004) 3.36

Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol (2006) 3.24

Hierarchical regulation of WASP/WAVE proteins. Mol Cell (2008) 2.86

B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity (2004) 2.60

Dental plaque biofilms: communities, conflict and control. Periodontol 2000 (2011) 1.79

A tyrosine-phosphorylated 12-amino-acid sequence of enteropathogenic Escherichia coli Tir binds the host adaptor protein Nck and is required for Nck localization to actin pedestals. Mol Microbiol (2002) 1.73

The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol (2003) 1.67

Tails of two Tirs: actin pedestal formation by enteropathogenic E. coli and enterohemorrhagic E. coli O157:H7. Curr Opin Microbiol (2003) 1.56

Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans. Infect Immun (2006) 1.55

Decorin-binding proteins A and B confer distinct mammalian cell type-specific attachment by Borrelia burgdorferi, the Lyme disease spirochete. Proc Natl Acad Sci U S A (2003) 1.50

Enterohaemorrhagic Escherichia coli exploits a tryptophan switch to hijack host f-actin assembly. Structure (2012) 1.47

Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc Natl Acad Sci U S A (2009) 1.46

Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspF(U). Nature (2008) 1.43

Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol (2012) 1.43

Occurrence and clinical relevance of Mycobacterium chimaera sp. nov., Germany. Emerg Infect Dis (2008) 1.42

Solving a sticky problem: new genetic approaches to host cell adhesion by the Lyme disease spirochete. Mol Microbiol (2005) 1.41

Fluorescence in situ hybridization (FISH) for direct visualization of bacteria in periapical lesions of asymptomatic root-filled teeth. Microbiology (2003) 1.41

Clustering of Nck by a 12-residue Tir phosphopeptide is sufficient to trigger localized actin assembly. J Cell Biol (2004) 1.39

Novel mass spectrometry-based tool for genotypic identification of mycobacteria. J Clin Microbiol (2004) 1.37

Are putative periodontal pathogens reliable diagnostic markers? J Clin Microbiol (2009) 1.37

Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection. Infect Immun (2008) 1.36

Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proc Natl Acad Sci U S A (2009) 1.34

Exploiting pathogenic Escherichia coli to model transmembrane receptor signalling. Nat Rev Microbiol (2006) 1.34

Nck-independent actin assembly is mediated by two phosphorylated tyrosines within enteropathogenic Escherichia coli Tir. Mol Microbiol (2005) 1.32

High frequency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol (2011) 1.26

Adaptation of the Lyme disease spirochaete to the mammalian host environment results in enhanced glycosaminoglycan and host cell binding. Mol Microbiol (2003) 1.24

Filifactor alocis--involvement in periodontal biofilms. BMC Microbiol (2010) 1.19

The immune reconstitution inflammatory syndrome in whipple disease: a cohort study. Ann Intern Med (2010) 1.17

Opsonophagocytosis-inhibiting mac protein of group a streptococcus: identification and characteristics of two genetic complexes. Infect Immun (2002) 1.16

The ArcA regulon and oxidative stress resistance in Haemophilus influenzae. Mol Microbiol (2007) 1.14

Bgp, a secreted glycosaminoglycan-binding protein of Borrelia burgdorferi strain N40, displays nucleosidase activity and is not essential for infection of immunodeficient mice. Infect Immun (2006) 1.13

Intimate host attachment: enteropathogenic and enterohaemorrhagic Escherichia coli. Cell Microbiol (2013) 1.12

Histone acetyltransferase Rtt109 is required for Candida albicans pathogenesis. Proc Natl Acad Sci U S A (2010) 1.12

Enterohaemorrhagic and enteropathogenic Escherichia coli Tir proteins trigger a common Nck-independent actin assembly pathway. Cell Microbiol (2007) 1.11

Molecular detection of Treponema denticola and Porphyromonas gingivalis in carotid and aortic atheromatous plaques by FISH: report of two cases. J Med Microbiol (2005) 1.11

Self-association of EPEC intimin mediated by the beta-barrel-containing anchor domain: a role in clustering of the Tir receptor. Mol Microbiol (2004) 1.11

Increased adherence and actin pedestal formation by dam-deficient enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol (2007) 1.09

MyD88- and Bruton's tyrosine kinase-mediated signals are essential for T cell-independent pathogen-specific IgM responses. J Immunol (2007) 1.09

Enterohaemorrhagic Escherichia coli Tir requires a C-terminal 12-residue peptide to initiate EspF-mediated actin assembly and harbours N-terminal sequences that influence pedestal length. Cell Microbiol (2006) 1.08

Repetitive N-WASP-binding elements of the enterohemorrhagic Escherichia coli effector EspF(U) synergistically activate actin assembly. PLoS Pathog (2008) 1.08

Impaired immune functions of monocytes and macrophages in Whipple's disease. Gastroenterology (2009) 1.07

Allelic variation of the Lyme disease spirochete adhesin DbpA influences spirochetal binding to decorin, dermatan sulfate, and mammalian cells. Infect Immun (2011) 1.06

EspFU, a type III-translocated effector of actin assembly, fosters epithelial association and late-stage intestinal colonization by E. coli O157:H7. Cell Microbiol (2007) 1.06

High prevalence of treponemes in bovine digital dermatitis-a molecular epidemiology. Vet Microbiol (2008) 1.04

Adjunctive antimicrobial therapy of periodontitis: long-term effects on disease progression and oral colonization. J Periodontol (2005) 1.04

Recognition of tandem PxxP motifs as a unique Src homology 3-binding mode triggers pathogen-driven actin assembly. Proc Natl Acad Sci U S A (2010) 1.04

Spt3 plays opposite roles in filamentous growth in Saccharomyces cerevisiae and Candida albicans and is required for C. albicans virulence. Genetics (2002) 1.04

Transcriptional regulators of the GAD acid stress island are carried by effector protein-encoding prophages and indirectly control type III secretion in enterohemorrhagic Escherichia coli O157:H7. Mol Microbiol (2011) 1.02

Complement factor H-binding protein, a putative virulence determinant of Borrelia hermsii, is an antigenic target for protective B1b lymphocytes. J Immunol (2008) 1.01

Point mutants of EHEC intimin that diminish Tir recognition and actin pedestal formation highlight a putative Tir binding pocket. Mol Microbiol (2002) 1.01

Spirochete-platelet attachment and thrombocytopenia in murine relapsing fever borreliosis. Blood (2003) 1.01

A novel murine infection model for Shiga toxin-producing Escherichia coli. J Clin Invest (2012) 1.01

Intrarenal abscesses due to Ureaplasma urealyticum in a transplanted kidney. J Clin Microbiol (2007) 1.00

Targeting type III secretion in Yersinia pestis. Antimicrob Agents Chemother (2008) 1.00

In vitro CpG methylation increases the transformation efficiency of Borrelia burgdorferi strains harboring the endogenous linear plasmid lp56. J Bacteriol (2008) 1.00

Enteropathogenic and enterohemorrhagic E. coli: ecology, pathogenesis, and evolution. Front Cell Infect Microbiol (2013) 0.98

Molecular epidemiology and spatial distribution of Selenomonas spp. in subgingival biofilms. Eur J Oral Sci (2010) 0.98

Enterohemorrhagic E. coli requires N-WASP for efficient type III translocation but not for EspFU-mediated actin pedestal formation. PLoS Pathog (2010) 0.97

Russell body duodenitis: a histopathological and molecular approach to a rare clinical entity. Pathol Res Pract (2012) 0.97

Listeria monocytogenes infection induces prosurvival metabolic signaling in macrophages. Infect Immun (2011) 0.97

Co-localized or randomly distributed? Pair cross correlation of in vivo grown subgingival biofilm bacteria quantified by digital image analysis. PLoS One (2012) 0.96

IL-7-dependent B lymphocytes are essential for the anti-polysaccharide response and protective immunity to Streptococcus pneumoniae. J Immunol (2010) 0.94

Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease. J Infect (2013) 0.93

The EHEC type III effector NleL is an E3 ubiquitin ligase that modulates pedestal formation. PLoS One (2011) 0.91

Evaluation of peptide nucleic acid-fluorescence in situ hybridization for identification of clinically relevant mycobacteria in clinical specimens and tissue sections. J Clin Microbiol (2006) 0.91

Rapid and accurate diagnosis of human intestinal spirochetosis by fluorescence in situ hybridization. J Clin Microbiol (2009) 0.91

Involvement of Guggenheimella bovis in digital dermatitis lesions of dairy cows. Vet Microbiol (2007) 0.91

Allele- and tir-independent functions of intimin in diverse animal infection models. Front Microbiol (2012) 0.91

Enhanced Actin Pedestal Formation by Enterohemorrhagic Escherichia coli O157:H7 Adapted to the Mammalian Host. Front Microbiol (2011) 0.90

Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever. Proc Natl Acad Sci U S A (2011) 0.90

Role of the innate immune system in autoimmune inflammatory demyelination. Curr Med Chem (2008) 0.90

Immunopathology of immune reconstitution inflammatory syndrome in Whipple's disease. J Immunol (2013) 0.88

Let them fly or light them up: matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry and fluorescence in situ hybridization (FISH). APMIS (2005) 0.86

Fluorescence in situ hybridisation (FISH) accelerates identification of Gram-positive cocci in positive blood cultures. Int J Antimicrob Agents (2008) 0.86

Relapsing fever spirochetes contain chromosomal genes with unique direct tandemly repeated sequences. Infect Immun (2005) 0.86

Structural basis for complex formation between human IRSp53 and the translocated intimin receptor Tir of enterohemorrhagic E. coli. Structure (2011) 0.85

Identification of a novel prophage regulator in Escherichia coli controlling the expression of type III secretion. Mol Microbiol (2011) 0.83

Validation of an rpoB gene PCR assay for detection of Tropheryma whipplei: 10 years' experience in a National Reference Laboratory. J Clin Microbiol (2013) 0.82

A view on Bartonella quintana endocarditis--confirming the molecular diagnosis by specific fluorescence in situ hybridization. Diagn Microbiol Infect Dis (2007) 0.82

Molecular characterization of Borrelia persica, the agent of tick borne relapsing fever in Israel and the Palestinian Authority. PLoS One (2010) 0.82

Toll-like receptor 2 deficiency results in impaired antibody responses and septic shock during Borrelia hermsii infection. Infect Immun (2010) 0.82

Association of Treponema spp. with canine periodontitis. Vet Microbiol (2007) 0.82

Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice. J Immunol (2014) 0.81

The transcriptional repressor BLIMP1 curbs host defenses by suppressing expression of the chemokine CCL8. J Immunol (2014) 0.81

Efficient B cell responses to Borrelia hermsii infection depend on BAFF and BAFFR but not TACI. Infect Immun (2013) 0.81

T-cell-independent immune responses do not require CXC ligand 13-mediated B1 cell migration. Infect Immun (2010) 0.81

Induction of distinct neurologic disease manifestations during relapsing fever requires T lymphocytes. J Immunol (2010) 0.80

Cortactin recruitment by enterohemorrhagic Escherichia coli O157:H7 during infection in vitro and ex vivo. Infect Immun (2008) 0.80

The ability of an attaching and effacing pathogen to trigger localized actin assembly contributes to virulence by promoting mucosal attachment. Cell Microbiol (2014) 0.80

Deciphering the role of Toll-like receptors in humoral responses to Borreliae. Front Biosci (Schol Ed) (2012) 0.79

Analysis of the periodontal microbiota in childhood-type hypophosphatasia. Int J Med Microbiol (2006) 0.79

Daptomycin concentrations in valve tissue and vegetation in patients with bacterial endocarditis. Antimicrob Agents Chemother (2012) 0.79

Intraoral dissemination of treponemes after periodontal therapy. Clin Oral Investig (2004) 0.79